Related Experiment Video
Updated: Apr 19, 2026

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
Published on: May 11, 2015
Personalized medicine in Type 2 Diabetes.
1Center for Personalized Medicine, China Medical University Hospital, Taichung, Taiwan ; Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.
Genetic factors significantly influence type 2 diabetes (T2D) risk and complications. Genetic profiling can identify high-risk individuals and predict responses to oral antidiabetic drugs, aiding personalized medicine approaches.
Area of Science:
- Endocrinology and Metabolism
- Human Genetics
- Pharmacogenomics
Background:
- Type 2 Diabetes (T2D) is a growing global health issue, with increasing prevalence in Asia, particularly Taiwan.
- Both environmental and genetic factors contribute to T2D development and its associated complications.
- Genetic association studies highlight specific genetic variations (polymorphisms) linked to T2D risk and drug response.
Purpose of the Study:
- To review the impact of genetic profiling on Type 2 Diabetes and its complications.
- To explore the pharmacogenetics and pharmacogenomics of oral antidiabetic medications.
- To utilize a specific study population from Taiwan as illustrative examples.
Main Methods:
- Review of existing genetic association studies.
- Analysis of genetic profiling data within a defined study population.
- Exploration of pharmacogenetic and pharmacogenomic literature on oral antidiabetic drugs.
Main Results:
- Genetic variations play a crucial role in determining individual susceptibility to Type 2 Diabetes.
- Specific genetic markers can predict the risk of developing diabetes complications.
- Genetic information can guide the selection and efficacy of oral antidiabetic drug therapies.
Conclusions:
- Genetic profiling offers a promising avenue for personalized risk assessment and management of Type 2 Diabetes.
- Understanding the genetic basis of T2D can lead to more effective and tailored pharmacotherapy.
- Further research into pharmacogenomics is essential for optimizing oral antidiabetic drug treatment.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type II Diabetes I: Introduction
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
